Skip to content

Released Aug 12, 2019, after the close

10-Q filed Aug 12, 2019, 43 days after period end · 0001213900-19-015337

Q1 2019 · 10-Q
Revenue—
Net Income-$20.06MN/M vs Q1 2018N/M vs Q4 2018
EPS Diluted-$0.52no prior Q1 2018 on fileno prior Q4 2018 on file
Operating Income-$92,342—
Operating Cash Flow-$8,332,000—
Free Cash Flowderived-$8,332,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2019Q1 2018
Net Income-$20.06M-$4.37M
EPS Diluted-$0.52—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Immunovant, Inc. · CIK 1764013 · Engraved from SEC EDGAR